Dr. Mahalaxmi Andheria brings with her an experience of more than 15 years in the Pharma & Biotech Industry. She has been actively involved in Formulation R&D for 5 years before she decided to switch to IPR and thereafter IPR has been her primary area of focus. Dr. Andheria is a PhD in...

Mr Jeff Baxter, Chief Executive Officer, VBI Vaccines

Dr Sudha Chivukula, Principal Scientist, Shantha Biotechnics

Dr. Sudha Chivukula is a Ph.D in Biochemistry from Andhra University and has several years of R&D experience in the Biotechnology industry. At Shantha, she has held scientific and managerial positions working in the areas of translation research, taking new vaccine candidates from conceptual...

Dr Sudha Chivukula, Principal Scientist, Shantha Biotechnics

Tarek Hussain, Health Consultant, Unicef

Srinivas Kosaraju, Vice President, Biological E Ltd

Mr Xiang Liang Lin, Business Development Executive, ESCO Global

Dr Hunchi Lin, Chief Executive Officer, Global BioPharma

Ms Annie Mo, Program Officer, N.I.H.

Dr. Annie Mo has worked in the areas of immunology, vaccinology, and vaccine and immunotherapeutics for over 20 years, and had held positions of increasing responsibility in the biotechnology and pharmaceutical industries, and in the Federal Government. She pursued her Ph.D. in viral immunology...